Crispr Therapeutics Ag (0VRQ)
LSE
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -13.437 | -22.183 | -43.395 | 8.595 | -24.104 | 16.492 | -26.033 | -6.869 |
Return on Equity (%) | -19.908 | -32.498 | -56.887 | 10.042 | -26.798 | 18.587 | -30.418 | -8.174 |
Return on Invested Capital (%) | -13.204 | -33.057 | -57.642 | 10.117 | -27.05 | 18.773 | -31.084 | -8.364 |
Operating Margin (%) | -284.043 | -162.47 | -5263.38 | 23.242 | -48408.345 | 41.48 | -54298.831 | -40.603 |
Net Profit Margin (%) | -448.819 | -166.737 | -5281.082 | 23.087 | -48520.862 | 41.276 | -54271.703 | -41.381 |
Book Value Per Share | 5.852 | 4.619 | 7.558 | 15.451 | 22.513 | 31.237 | 23.942 | 23.572 |
Earnings Per Share | -0.584 | -1.684 | -3.182 | 1.1 | -4.72 | 4.917 | -8.3 | -1.923 |
Cash Per Share | 7.944 | 5.907 | 8.807 | 15.527 | 15.81 | 12.017 | 2.705 | 4.876 |
Working Capital Per Share | 7.507 | 5.762 | 8.459 | 15.307 | 21.949 | 29.913 | 22.11 | 22.527 |
Operating Profit Per Share | 2.396 | 1.01 | 0.06 | 5.193 | 0.096 | 11.99 | 0.305 | 5.547 |
EBIT Per Share | -0.572 | -1.641 | -3.171 | 1.107 | -4.709 | 4.941 | -8.304 | -1.887 |
EBITDA Per Share | -0.572 | -1.641 | -3.171 | 1.107 | -4.709 | 4.941 | -8.304 | -1.887 |
Free Cash Flow Per Share | -0.531 | -1.566 | -3.196 | 1.132 | -4.596 | 5.747 | -8.134 | -2.053 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 39,72M | 40,59M | 51,85M | 60,78M | 73,92M | 76,81M | 78,33M | 79,87M |
Capitalisation boursière | 5,16B |
Ratio cours/bénéfice | -33,59 |
Ratio prix/ventes | 13,9 |
Ratio prix/liquidités | 13,25 |
Ratio prix/valeur comptable | 2,74 |
Rendement de dividende | - |
Actions en circulation | 79,87M |
Volume moyen (1 semaine) | 6,58k |
Volume moyen (1 mois) | 6,04k |
Variation sur 52 semaines | 0,00% |
Plus haut sur 52 semaines | 64,60 |
Plus bas sur 52 semaines | 64,60 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales